Conference Coverage
Conference Coverage
Androgen receptor screening not ready for triple-negative breast cancer
LAS VEGAS – Screening for androgen receptors is currently encouraged only in the context of clinical trials for triple-negative breast cancer.
Conference Coverage
Two new biomarkers show breast cancer validity
BRUSSELS – The two markers, high intratumor heterogeneity of estrogen-receptor density and pSTAT3 expression, are promising but need further...
Conference Coverage
Biomarkers come up empty for ribociclib targeting
BRUSSELS – Hazard ratio benefits from ribociclib plus letrozole, compared with letrozole alone, were similar regardless of the biomarker levels....
Conference Coverage
Breast density is no reason to perform MRI
Among women who underwent MRI before breast cancer surgery, those with high breast density had similar outcomes to those of women with low breast...
Conference Coverage
Radiation bests mastectomy for occult breast cancer
LAS VEGAS – Overall survival was better when women with occult breast cancer had axillary lymph node dissection and radiation, instead of...
Conference Coverage
Mastectomy unnecessary for some breast cancer recurrences
LAS VEGAS – Although mastectomy is the standard of care for tumor recurrence following lumpectomy and whole breast irradiation, a second...
Conference Coverage
Sutureless, guided lumpectomy produced clean margins in majority
Pain scores were low with sutureless guided lumpectomy, and all high-risk lesions were successfully removed.
Conference Coverage
VIDEO: Dr. Lisa Newman on triple negative breast cancer in African American women
LAS VEGAS – The heavy burden of triple negative and other aggressive breast cancers among African American women cannot be simplified to...
Conference Coverage
DCIS tool IDs axillary node biopsy candidates
A nomogram may encourage patients to have axillary nodal biopsy performed at the same time as core needle biopsy.
Conference Coverage
VIDEO: How to pick surgical margins with mixed breast lesions
LAS VEGAS – Breast surgeon Monica Morrow, MD, explains how to handle invasive carcinoma associated with DCIS.